Endonasal CNS Delivery System for Blood-Brain Barrier Impermeant Therapeutic Oligonucleotides Using Heterotopic Mucosal Engrafting

The most significant obstacle in the treatment of neurological disorders is the blood-brain barrier (BBB), which prevents 98% of all potential neuropharmaceuticals from reaching the central nervous system (CNS). Brain derived neurotrophic factor (BDNF) is one of the most intensely studied targets in...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawar, Grishma, Parayath, Neha N., Sharma, Aditya A., Coito, Carlos, Khorkova, Olga, Hsiao, Jane, Curry, William T., Amiji, Mansoor M., Bleier, Benjamin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090932/
https://www.ncbi.nlm.nih.gov/pubmed/33953687
http://dx.doi.org/10.3389/fphar.2021.660841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090932/
https://www.ncbi.nlm.nih.gov/pubmed/33953687
http://dx.doi.org/10.3389/fphar.2021.660841

Ejemplares similares